Adverse Events and Real-World Outcomes of Intravenous Immunoglobulin in Dermatologic Diseases: A 20-Year Cohort Study.
- DOI
- 10.1093/ced/llag410
- Published
- 2026 Sep 17
- Container
- Clinical and experimental dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ced/llag410,
title = {Adverse Events and Real-World Outcomes of Intravenous Immunoglobulin in Dermatologic Diseases: A 20-Year Cohort Study.},
author = {Aydogan K and Ünlü CI and Öztürk F and Saricaoglu H and Baskan EB and Yazici S},
year = {2026},
journal = {Clinical and experimental dermatology},
doi = {10.1093/ced/llag410},
url = {https://doi.org/10.1093/ced/llag410}
}RIS
TY - JOUR TI - Adverse Events and Real-World Outcomes of Intravenous Immunoglobulin in Dermatologic Diseases: A 20-Year Cohort Study. AU - Aydogan K AU - Ünlü CI AU - Öztürk F AU - Saricaoglu H AU - Baskan EB AU - Yazici S PY - 2026 JO - Clinical and experimental dermatology DO - 10.1093/ced/llag410 UR - https://doi.org/10.1093/ced/llag410 ER -
APA
K, A., CI, Ü., F, Ö., H, S., EB, B., & S, Y. (2026). Adverse Events and Real-World Outcomes of Intravenous Immunoglobulin in Dermatologic Diseases: A 20-Year Cohort Study.. Clinical and experimental dermatology. https://doi.org/10.1093/ced/llag410
Source records
- pubmed · retrieved 2026-09-25T02:38:07.415Z